Preclinical evaluation of the AR inhibitor enzalutamide in triple-negative breast cancer cells

  • Francesco Caiazza
  • , Alyson Murray
  • , Stephen F. Madden
  • , Naoise C. Synnott
  • , Elizabeth J. Ryan
  • , Norma O'Donovan
  • , John Crown
  • , Michael J. Duffy

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Preclinical evaluation of the AR inhibitor enzalutamide in triple-negative breast cancer cells'. Together they form a unique fingerprint.

Immunology and Microbiology

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience